The Biodegradable Stents Market is estimated at US$459.5 million in 2026 and is projected to grow at a CAGR of 8% to reach US$850.5 million by 2034.
The intended clinical use and degradation behavior shape evaluation; product-specific evidence is essential to meaningful comparisons.
This product will be delivered within 1-3 business days.
Market Overview
The Biodegradable Stents Market covers stent products designed with biodegradable or bioresorbable characteristics.The intended clinical use and degradation behavior shape evaluation; product-specific evidence is essential to meaningful comparisons.
Market Segmentation
By Material
- Polymeric (PLLA, PCL, PDLA blends)
- Metallic (Magnesium, Iron, Zinc alloys)
By Drug Type
- Limus-based (Sirolimus, Everolimus, Novolimus)
- Paclitaxel-based
By Application
- Coronary Artery Disease (CAD)
- Peripheral Artery Disease (PAD)
- Gastrointestinal Strictures
- Ureteral Obstruction
- Airway Stenosis
By End User
- Hospitals
- Cardiac Catheterization Labs
- Ambulatory Surgical Centers
Key Companies Analysed
- Abbott
- Biotronik
- Elixir Medical
- Kyoto Medical Planning
- Arterius
- Amaranth Medical
- Reva Medical
- Sahajanand Medical Technologies
- Meril Life Sciences
- Boston Scientific
- Medtronic
- Biosensors International
- Terumo
- Lepu Medical
- Translumina
- OrbusNeich
- MicroPort
- SINOMED
- Alvimedica
- Cardinal Health
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Biodegradable Stents Market Overview
3. Biodegradable Stents Market Dynamics
4. Biodegradable Stents Market Strategic Analysis
5. Global Biodegradable Stents Market Size, Share and Forecast, 2025-2034
6. North America Biodegradable Stents Market Outlook to 2034
7. Europe Biodegradable Stents Market Outlook to 2034
8. Asia-Pacific Biodegradable Stents Market Outlook to 2034
9. Middle East and Africa Biodegradable Stents Market Outlook to 2034
10. South and Central America Biodegradable Stents Market Outlook to 2034
11. Biodegradable Stents Market Competitive Landscape
12. Appendix
Companies Mentioned
- Abbott
- Biotronik
- Elixir Medical
- Kyoto Medical Planning
- Arterius
- Amaranth Medical
- Reva Medical
- Sahajanand Medical Technologies
- Meril Life Sciences
- Boston Scientific
- Medtronic
- Biosensors International
- Terumo
- Lepu Medical
- Translumina
- OrbusNeich
- MicroPort
- SINOMED
- Alvimedica
- Cardinal Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 459.5 Million |
| Forecasted Market Value ( USD | $ 850.5 Million |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
